Background: Despite potential benefits, the practice of incorporating pharmacogenomics
(PGx) results in clinical decisions has yet to diffuse widely. In this study, we conducted a …

The implementation of clinical pharmacogenetics in daily practice is limited for various
reasons. Today, however, it is a discipline in full expansion. Accordingly, in the recent times …

Pharmacogenomics is one of the emerging approaches to precision medicine, tailoring drug
selection and dosing to the patient's genetic features. In recent years, several …

Background: Awareness about the importance of implementing DPYD pharmacogenetics in
clinical practice to prevent severe side effects related to the use of fluoropyrimidines has …

Screening potential drug–drug interactions, drug–gene interactions, contraindications, and
other factors is crucial in clinical practice. However, implementing these screening concepts …

Improvements in next-generation sequencing (NGS) technology and computer systems
have enabled personalized therapies based on genomic information. Recently, health …

Idiopathic pulmonary fibrosis (IPF) has traditionally been considered the archetype of
progressive fibrotic interstitial lung diseases (f-ILDs), but several other f-ILDs can also …

Pharmacogenomic information must be incorporated into electronic health records (EHRs)
with clinical decision support in order to fully realize its potential to improve drug therapy …

Background: Pharmacogenomic factors affect the susceptibility to drug–drug interactions
(DDI). We identified drug interaction perpetrators among the drugs prescribed to a cohort of …

Digital health, an emerging scientific domain, attracts increasing attention as artificial
intelligence and relevant software proliferate. Pharmacogenomics (PGx) is a core …